Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
GSK or TECH: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 25'th Mar 2024
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Techne (TECH). But which of these two stocks is more attractive to value i
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
01:30pm, Thursday, 21'st Mar 2024
GSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month in the United States. The company intends to start this in 2025.
GSK to cap out-of-pocket inhaler costs in US
05:01pm, Wednesday, 20'th Mar 2024
British pharmaceutical giant GSK said on Wednesday it will cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines for eligible patients in the United St
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
12:46pm, Wednesday, 20'th Mar 2024
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
GSK (GSK) Increases Yet Falls Behind Market: What Investors Need to Know
07:05pm, Tuesday, 19'th Mar 2024
In the most recent trading session, GSK (GSK) closed at $42.32, indicating a +0.43% shift from the previous trading day.
Jemperli Cancer Drug: What To Know As GSK Says It Improves Survival For Uterine Cancer Patients
11:22am, Saturday, 16'th Mar 2024
Jemperli, a cancer drug manufactured by GlaxoSmithKline, improved survival for patients diagnosed with a form of uterine cancer by more than one year, the British drugmaker said Saturday, the latest f
GSK PLC Sponsored ADR (GSK) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Thursday, 14'th Mar 2024
Glaxo (GSK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Inflation Remains Sticky in February: 5 Safe Picks
10:56am, Wednesday, 13'th Mar 2024
We have narrowed our search to five low-beta stocks with a solid dividend yield. These are: TAP, TSN, TM, GSK and BAH.
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?
10:46am, Wednesday, 13'th Mar 2024
Here is how GSK (GSK) and Capricor Therapeutics (CAPR) have performed compared to their sector so far this year.
GSK: Has Blenrep's blockbuster status been restored?
03:31am, Friday, 08'th Mar 2024
GSK PLC (LSE:GSK, NYSE:GSK) cancer discovery Blenrep's blockbuster potential has been 'reawakened', according to Shore Capital. The broker was commenting after Thursday's phase III results, which sh
GSK's blood cancer drug meets main goal in late-stage trial; analysts tout comeback
06:41am, Thursday, 07'th Mar 2024
GSK said on Thursday a study showed its experimental drug Blenrep helped extend survival in patients with a type of blood cancer without symptoms worsening, marking a potential comeback for the drug a
GSK vs. VRTX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 05'th Mar 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with GSK (GSK) and Vertex Pharmaceuticals (VRTX). But which of these two stocks presents investors with the better
WHO says resistance to GSK's HIV drug is growing
11:32am, Tuesday, 05'th Mar 2024
The World Health Organization said on Tuesday that data shows resistance to the drug is growing in patients receiving GSK's HIV drug, dolutegravir.
GSK's new HIV drug formula could support longer dosing intervals
01:50pm, Monday, 04'th Mar 2024
GSK said on Monday a new formulation of its HIV prevention and treatment drug could potentially be administered at least every four months, an improvement from the previous requirement of dosing every
Glaxo (GSK) Up 3.1% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 01'st Mar 2024
Glaxo (GSK) reported earnings 30 days ago. What's next for the stock?
